Skip to content

Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III

Behavioral Challenges in Children With Mucopolysaccharidosis Type I-III and Parental Coping Strategies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03161171
Enrollment
34
Registered
2017-05-19
Start date
2017-07-06
Completion date
2017-11-13
Last updated
2017-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior Disorders, Coping Behavior, Mucopolysaccharidosis Type I, Mucopolysaccharidosis Type II, Mucopolysaccharidosis Type III

Brief summary

The study quantitates behavioral challenges in mucopolysaccharidosis type I-III and parental coping strategies

Detailed description

This is a prospective, cross-sectional, observational study quantitatively assessing 1. challenging behavior in children with MPS, an orphan, progressive, neurodegenerative metabolic disorder, and 2. parental coping strategies for this challenging behavior. Patients registered at the German Society for Mucopolysacchardoses giving written informed consent are eligible. The study is based on questionnaires. IRB approval was obtained.

Interventions

OTHERThis is an observational study

This is an observational study

Sponsors

University Hospital Heidelberg
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of mucopolysaccharidosis type I, II or III * Written informed consent * Patient is registered at the German Society for Mucopolysaccharidosis

Exclusion criteria

* Patient / Family does not give written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Coping strategies for challenging behavior and for family burden in mucopolysaccharidosis type I-III10 minutesassessed by visual analogue scale

Secondary

MeasureTime frameDescription
Quantity of behavioral abnormalities in children with mucopolysaccharidosis type I-III10 minutesassessed by visual analogue scale
Intensity of behavioral abnormalities in children with mucopolysaccharidosis type I-III10 minutesassessed by visual analogue scale
Psychosocial burden in families with mucopolysaccharidosis type I-III10 minutesassessed by visual analogue scale

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026